Marek Wróbel

Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients

2018 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové

Publication